Professional Documents
Culture Documents
ISFAP 2021 Paper 47 Review01
ISFAP 2021 Paper 47 Review01
Robeth Viktoria Manurung1, a), Ahmad Rashid2, Yaya Sulaeman1 and Isa Anshori2
1
Research Center for Electronics & Telecommunication, Indonesian Institute of Sciences
Jl. Cisitu No.21/154D, Komplek LIPI Sangkuriang, Bandung, Jawa Barat, Indonesia
2
Bandung Institute of Technology
Jl. Ganesa No.10, Bandung, Jawa Barat, Indonesia
a)
Corresponding author: robeth.viktoria.manurung@lipi.go.id
Abstract. This study is reporting the thick film sensor or screen-printed carbon electrode (SPCE) modified by Carbon
Nanotube (CNT) for electrochemical sensing of dopamine (DA). The modification was carried out using the drop-casting
method. The carbon surface of the SPCE working electrode has been modified by several different materials such as
FMWCNT (with and without Nafion), MWCNT /AgNP, and MWCNT-DMF. Cyclic Voltammetry (CV) and Differential
Pulsed Voltammetry (DPV) testing on dopamine showed that FMWCNT (with Nafion), MWCNT /AgNP, and MWCNT-
DMF had a sensitivity of 56.9; 39.0 and 11.6 µAmM-1cm-2, the detection limit is 300, 220, and 8.1 nM, the quantification
limit is 1.01; 0.75, and 0.027 μM, and with an average measurement error of 0.29; 0.53, and 19.65, respectively. The CNT
modified SPCE has been successfully fabricated and applied as an electrochemical sensor for dopamine and shows good
sensitivity and selectivity.
INTRODUCTION
Dopamine or (2-aminoethyl) benzene-1,2-diol (DA) plays an essential role as neurotransmitters (neuromediators)
responsible for sending neural signals in human and animal bodies [1–5]. It is found in almost all brain tissue,
especially in the basal ganglia and substantia nigra; therefore, damage to brain tissue due to cerebral hypoxia can
affect extracellular dopamine content. The amount of dopamine concentration in the human body is significant for
learning, memory, human behavior, and cardiovascular and renal systems [1–3], [6–8]. Deficiency of dopamine can
cause Parkinson’s disease, schizophrenia, and other health problems such as drug addiction [9–12]. The average range
of dopamine concentration is from 0.1 to 0.4 nM in the blood and 0.1 to 2 μM in urine [13], [14]. Thus, in actual
samples, dopamine must be measured at relatively low concentrations and in the presence of various interferences, in
particular ascorbic acid (AA) and uric acid (UA). The measurement technique of dopamine and other catecholamines
which has used in clinics is liquid chromatography [15]. However, electrochemical methods of dopamine control
attract increasing attention because electrochemical sensing is promising because of a rapid, sensitive, selective, and
low-cost detection of various biomolecular analytes. Among electrochemical methods of dopamine sense, it was
reported on potentiometry with electrodes selective either to dopamine [16], [17]. or to ions involved in the dopamine
oxidation process, e.g IO4− [18]. Some data exhibited in reviews on several techniques of measurements of dopamine
show voltammetry as the predominant approach to measuring this analyte electrochemically [20-23]. Electrochemical
techniques are highly developed due to sensitive detection by simple procedures. Electrochemical methods can detect
dopamine because it has good electrochemical activity and is easily oxidized.
One application of the electrochemical method is the Screen-Printed Carbon Electrode (SPCE). SPCE is an
electrochemical strip electrode that consists of a working electrode and a counter electrode based on carbon, and a
reference electrode. However, this carbon-based electrode is still less selective, so modifications are needed to increase
the electrode selectivity and sensitivity to dopamine. Much research has been given attention to developing
nanomaterials, which are used to enhance the performance of electrochemical sensors. Nanomaterials are commonly
used to take advantage of a large surface area to mobilize biomolecules. This usually increases the number of binding
sites available to detect a specific chemical analyte [24]. Electrochemical sensors use a variety of nanomaterials to
enhance performance. Carbon nanotubes (CNTs) are among the most interesting materials due to their unique
electronic, chemical, and mechanical properties [25]. CNT consists of SP2 carbon units with a diameter of several
nanometers and a length of several microns. CNT can be synthesized into two groups, multi-wall (MW) and single-
wall (SW), by electric arc discharge, laser evaporation, and chemical vapor deposition methods. CNT behaves like
metals or semicircles depending on the diameter and degree of helically. Due to the high electronic conductivity for
electron transfer reactions and better electrochemical and chemical stability in aqueous and non-aqueous solutions,
they are suitable for modifying various electrodes. Furthermore, it is very promising to create efficient electrochemical
sensors using electrodes modified by CNTS, as they stimulate electron transfer reactions in many small biologically
essential molecules and large biomolecules.
In this study, three types of materials will be used to modify the surface of the SPCE working electrode. Four types
of materials to be synthesized include FMWCNT (Functionalized Multi-wall carbon nanotube) (without and with
nafion), MWCNT/AgNPs, and MWCNT-DMF. Furthermore, electrochemical testing of the analyte can be carried out
using a potentiostat or galvanostat device by Cyclic Voltammetry (CV) and the analyte that will be used in this test is
a sample of dopamine.
Figure 3. SEM image of (a) CNT by adding composition H2SO4:HNO3; 3:1, (b) AgNPs decorated on SPCE-MWCNT surface,
(c) MWCNT formed on SPCE surface.
AgNPs has been succeed to fabricated on the surface of MWCNT modified SPCE electrode by SEM image
confirmation on Figure 3b. Generally, the oxidized MWCNT has reduced the size with the average diameter range
from 100 – 150 nm (Aqel et.al). Interestingly, the SEM image on Figure 3c showed MWCNT has diameter around 35
– 80 nm.
Figure 4. The voltammogram spectra of bare SPCE vs CNT modified SPCE in 0.5 nM Dopamine solution.
The voltammogram spectra confirmed the CNT modification has been improve the oxidation peak current in 0.5
nM Dopamin in PBS buffer PH 7. The oxidation peak current of each SPCE can be measured as follow, bare SPCE,
FMWCNT (without nafion), FMWCNT (with nafion) , MWCNT/AgNP and MWCNT-DMF has oxidation peak
current 0,2165; 0,61408; 0,27304; 0,30233 and 0,32656 mA/cm2, respectively. Hence, MWCNT/AgNP modified
SPCE has superior oxidation peak current compare than another SPCE modification and bare SPCE as well. Based on
voltammogram spectra, it is clearly seen that FMWCNT (with nafion) has similar peak with MWCNT/AgNPs,
however, MWCNT/AgNPs has voltage separation gap between oxidation and reduction peak shorter than FMWCNT
(with Nafion). It is indicating that the electron transfer on MWCNT/AgNPs faster than other SPCE modification
including bare SPCE.
Based on the results of the CV measurements of the four SPCEs modification vs dopamine concentration range of
0.1 – 1.0 mM, it is seen that there is an increase in the current density value along with the increase in the concentration
of dopamine compounds. This increase in current density occurs because the electrons released in the working solution
during the oxidation process of dopamine compounds tend to be more as the concentration of dopamine compounds
increases. In addition, the resulting oxidation peak was seen to shift to a greater working stress as the dopamine
concentration increased. This increase in working voltage is caused by the greater energy required by the electrode to
oxidize dopamine compounds (DA) to dopamine-quinone (DQ) when there is an increase in the concentration of the
dopamine solution. The sensitivity DA sensor based on four modifications: MWCNT-DMF, MWCNT/AgNP, and
FMWCNT (with and without nafion) are 3.82; 5.6; 9.2 and 3.51 x 10-5 A/cm2, respectively.
The detection limit (LoD) of measurement is the smallest concentration that can generate a signal that can be
measured by the sensor. LoD is determined by the equation:
LoD =!"#$ (1)
$
The Sb is the standard deviation of the measurement from the measurement with the smallest analyte concentration,
in this study, the measurements has been conducted for 5-7 times in 10 mM PBS solution pH 7.4. Then, b is the
gradient of the linear regression plot curve. Based on this equation, the detection limit values of MWCNT/AgNP,
MWCNT-DMF, and FMWCNT (with nafion) were 0.30; 0.22 and 0.0081 mM, respectively.
The measurement error of repeated measurements in 0.5 mM dopamine sample for MWCNT/AgNP, MWCNT-
DMF, and FMWCNT (with nafion) are 0.29%, 0.53 %, and 19.63%, respectively. The data indicated that the
measurement error of MWCNT/AgNP and MWCNT-DMF, has produced very low percentage compare than
FMWCNT with Nafion because the stability MWCNT/AgNP, MWCNT-DMF are better than FMWCNT.
CONCLUSION
In conclusion, a comprehensive study of electrochemical sensing platform for DA was developed based SPCE-
MWCNT/AgNPs, MWCNT-DMF, and FMWCNT (with and without nafion). Due to the high conductivity and
synergistic effects of MWCNT and AgNPs, the current response of DA is significantly improved. The detection limit
values of MWCNT/AgNP, MWCNT-DMF, and FMWCNT (with nafion) were 0.30; 0.22 and 0.0081 mM,
respectively. Additionally, among four modification which has been employed in SPCE, MWCNT/AgNP, MWCNT-
DMF showed good response for DA detection.
ACKNOWLEDGMENTS
This research was funded by National Research and Innovation Agency (BRIN/RistekDikti) under scheme
INSINAS Grant No. 12/INS/PPK/E4/2021. The authors thank the Research Center for Electronics and
Telecommunication, - Indonesian Institute of Sciences, Indonesia for supporting this work. The authors also
acknowledge the facilities, scientific and technical support from the Advanced Functional Materials (AFM)
Laboratory, ITB, and the Biotechnology Laboratory, Padjadjaran University, and all parties in Biomedical
Engineering Study Program, School of Electrical and Informatics Engineering, ITB, Bandung.
REFERENCES
1. K.A. Neve, J.K. Seamans, H. Trantham-Davidson, J Recept Signal Transduct. 24, 165–205 (2004).
2. W.J. Smeets and A. Gonzalez, Brain Res Rev. 33, 308–379 (2000).
3. A. Alcaro, R. Huber and J, Panksepp, Brain Res Rev. 56, 283–321 (2007).
4. R.M. Wightman, Anal Chem. 80, 769A–776A (1988).
5. R.M. Wightman, C. Amatore and R.C. Engstrom RC, Neuroscience. 25, 513–523 (1988).
6. B.J. Venton and R.M. Wightman, Anal Chem. 5, 414A–421A (2003).
7. F. Mora, G. Segovia and A. Del Arco, Brain Res. 1476, 71–85 (2012).
8. V. Hefco, K. Yamada and A. Hefco, Eur J Pharmacol. 475, 55–60 (2003).
9. A. Galvan and T. Wichmann, Clin Neurophysiol. 19, 1459–1474 (2008).
10. S.H. Kollins, and J.S. March, Biol Psychiatry. 62, 951–953 (2007)
11. J.W. Dalley and J.P. Roiser, Neuroscience. 215, 42–58 (2012).
12. M. Sofuoglu and R.A. Sewell, Addict Biol. 14, 119–129 (2009).
13. D.G. Gardner and D. Shoback, Greenspan’s Basic & Clinical Endocrinology. 9th ed. the McGraw-Hill Companies p. 857
(2011).
14. S. Melmed, K. Polonsky, P.R. Larsen, Williams Textbook of Endocrinology. 12th ed. Philadelphia: Saunders Company; p.
1920 (2011).
15. M. Tsunoda, Anal Bioanal Chem. 386, 506–514 (2006).
16. E. Wolyniec, M. Wysocka and M. Pruszynski M, Instrum Sci Technol. 35, 241–253 (2007).
17. I.S. Muratova, L.A. Kartsova and K.N. Mikhelson, Sens & Actuat B. 207, 900–906 (2015).
18. M.C. Montenegro and M.G. Sales, J Pharm Sci. 89, 876–884 (2000).
19. I.S. Muratova, K.N. Mikhelson KN and E. Yu Ermolenko, Sens & Actuat B. 232, 420–427 (2016).
20. J.F. Van Staden and R.I.S Van Staden RIS, Talanta. 102, 34–43 (2012).
21. K. Jackowska and P. Krysinski, Anal Bioanal Chem. 405, 3753–3771 (2013).
22. M. Hasanzadeh, N. Shadjou and M. De La Guardia, Tr Anal Chem. 86, 107–121 (2017).
23. S.J. Li, J.Z. He and M.J. Zhang, Electrochim Acta. 102, 58–65 (2013).
24. S.K. Padigi, R.K.K Reddy and S. Prasad, Biosens. Bioelectron. 22, 829-837 (2007).
25. G. Sun, S. Liu, K. Hua, X. Lv and L. Huang, Electrochem.Commun. 9, 2436-2440 (2007).